Alexander Lamley
Partner
Corporate
Qualifications
Memberships
Practice Areas
Alexander is a UK and US corporate lawyer, who advises businesses on mergers and acquisitions, equity and debt finance including early-stage investment by SAFEs, advance subscription agreements (ASAs) and other convertibles.
Alexander has assisted angel syndicates, VCTs and high net worth investors with advice on substantial investment into early-stage companies. Alexander supports businesses from start-up, through investment and exit. He also regularly advises on share incentive schemes for early stage companies (EMI and unapproved options and growth shares). Alexander has assisted a number of UK clients expand or set up in the US including by "Delaware flip".
Personal Biography
Alexander is a keen rock climber, musician and traveller. If he’s not at his desk, he can be found scaling a wall or crag somewhere nearby or standing in front of an amplifier.
Legal Experience
- Advising multiple UK companies on ‘flipping’ into a new US corporation and receiving US investment.
- Advising a data-log management company on receiving investment of $10m from a US VC.
- Advising Rhizocore Technologies on receiving £3.5m investment from US and Australian VCs
- Advising Bioliberty on receiving £2.2m investment from Archangel, Eos and Old College Capital
- Advising Carcinotech on its close of £4.2m investment led by Eos and Maven.
- Advising Wobble Genomics on its spin-out from University of Edinburgh and investment of £1.2m
- Advising Acu-flow on its spin-out from University of Glasgow and investment of £1.7m from Foresight Williams Technology and others
- Advising Tay Therapeutics on its spin-out from University of Dundee and investment of £1.6m pre-Series A funding
- Advising Mi:RNA on its spin-out from SRUC and seed investment
- Advising TenBio on its spin-out from University of Dundee and investment of £1m from Tricapital
- Advising Wellfish Diagnostics on its spin-out from University West of Scotland and investment of £1.2m from Kelvin Capital and Scottish Enterprise
- Advising Lifesciences and green impact investor syndicate on its £2.5m investment into a green chemicals start up
- Advising Wobble Genomics on its December 2023 close of £8.5m investment from BGF, Mercia, Eos and IQ Capital
- Providing US counsel to a Dutch VC fund on follow-on investment into a US based portfolio company
- Advising PE backed firm on design and implementation of growth share scheme